Synthesis of 2-methyl-4-aryl-4,6,7,8-tetrahydro-5(1H)-quinolone derivatives and their effects on potassium channels

Arzneimittel-Forschung/Drug Research

Volumn 58, Issue 12, 2008, Pages 659-665

  Öztürk, Gökçe Sevim ^a   Vural, Mert ^a   Gündüz, Miyase Gözde ^b   Şimşek, Rahime ^b   Sarioǧlu, Yusuf ^a   Şafak, Cihat ^b  

^a GAZI UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Potassium channel openers; Quinolones, effects on potassium channels, synthesis

Indexed keywords

2 METHYL 4 (2 THIENYL) 7 PHENYL 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE; 2 METHYL 4,7 DIPHENYL 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE; 2,6,6 TRIMETHYL 4 (2 THIENYL) 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE; 2,6,6 TRIMETHYL 4 (4 CHLOROPHENYL) 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE; 2,6,6 TRIMETHYL 4 PHENYL 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE; 2,7 DIMETHYL 4 (2 THIENYL) 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE; 2,7 DIMETHYL 4 (4 CHLOROPHENYL) 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE; 2,7 DIMETHYL 4 PHENYL 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE; 2,7,7 TRIMETHYL 4 (4 CHLOROPHENYL) 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE; 2,7,7 TRIMETHYL 4 (THIENYL) 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE; 2,7,7 TRIMETHYL 4 PHENYL 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE; 4,6,7,8 TETRAHYDRO 5(1H) QUINOLONE DERIVATIVE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; OMEGA CONOTOXIN GVIA; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM CHLORIDE; QUINOLONE DERIVATIVE; SPASMOLYTIC AGENT; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; BLADDER MUSCLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONCENTRATION RESPONSE; DETRUSOR MUSCLE; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSTIMULATION; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RABBIT; SMOOTH MUSCLE CONTRACTILITY; STRUCTURE ACTIVITY RELATION;

EID: 58149260333     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296568     Document Type: Article

References (38)

1. + Conduction and Selectivity. Science. 1988;280:69-77.
2. 1H-NMR Assignment and Secondary Structure of Black Mamba Dendrotoxin I, A Highly Selective Blocker of Voltage-Gated Potassium Channels. Eur J Biochem. 1993;211(V):813-820.
3. + Channel Inhibitör from Scorpian Venom. Biochemistry. 1997;36:6936-6940.
4. Simsek R, Ozkan M, Kismetli E, Uma S, Safak C. Some Arylacridine Derivatives Possessing Potassium Channel Opening Activity. Farmaco. 2004;59:939-943.
5. Berkan O, Saraç B, Simsek R, Yildirim S, Sarioglu Y, Safak C. Vasorelaxing Properties of Some Phenylacridine Type Potassium Channel Openers in Isolated Rabbit Thoracic Arteries. Eur J Med Chem. 2002;37(6):519-523.
6. Carroll WA, Altenbach RJ, Bai H, Brioni JD, Brune ME, Buckner SA, et al. Synthesis and Structure-activity Relationships of a Novel Series of 2,3,5,6,7,9-hexahidrothieno[3,2-b]quinolin-8(4H)-one-1,1-dioxide K(ATP) Channel Openers: Discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahidrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), A Potent K(ATP)opener That Selectively Inhibits Spontaneous Bladder Contractions, J Med Chem. 2004;47(12):3163-3179.
7. + Channels in Bladder Smooth Muscle Cells. J Pharmacol Exp Ther. 2001;296(3):669-75.
8. Davis-Taber R, Molinari EJ, Altenbach RJ, Whiteaker KL, Shieh CC, Rotert G, et al. A Novel High-affinity 1,4-dihidro-pyridine ATP-sensitive K+ Channel Opener: Characteriza-tion and Pharmacology of Binding. Mol Pharmacol. 2003;64(1):143-153.
9. Ohnmacht, JR, Cyrus J, Trainor, D, Forst, JM, Stein, MM, Haris, RJ. 4,6,7,8-Tetrahidro-5(1H)-quinolones Useful for the Treatment of Urinary Incontinence, US. Pat. 1995, 5.455,253.
10. Grant, TI, Zuzack, JS. Effects of Potassium Channel Blockers and Cromakalim (BRL 34915) on the mechanical Activity of Guinea Pig Detrusor Smooth Muscle. Pharmacol Exp Ther. 1991;259(3):1158-1164.
11. Erol, K, Ulak, G, Dönmez, T, Cingi, M.I, Alpan, RS, Özdemir, M. Effects of Vasoactive Intestinal Polypeptide on Isolated Rat Urinary Gladder Smooth Muscle. Urol Int. 1992;49:151-153.
12. Drizin I, Holladay MW, Yi L, Zhang HQ, Gopalakrishnan S, Gopalakrishnan M, et al. Structure-Activity Studies for a Novel Series of Tricyclic Dihidropyrimidines as K(ATP) Channel Openers (KCOs). Bioorg Med Chem Lett. 2002; 12(11):1481-1484.
13. Nicoll RA, Malenka RC, Kauer JA. Functional Comparison of Neurotransmitter Receptor Subtypes in Mammalian Central Nervous System. Physiol Rev. 1990;70(2):513-65.
14. Roeper J, Pongs O. Presynaptic Potassium Channels. Curr Opin Neurobiol. 1996;6(3):338-341.
15. Mathie A, Wooltorton JR, Watkins CS. Voltage-activated Potassium Channels in Mammalian Neurons and Their Block by Novel Pharmacological Agents. Gen Pharmacol. 1998;30(1):13-24.
16. 2 Muscarinic Receptor-mediated Inhibition of Noradrenaline Release From the Rat Stomach. J Pharmacol Sci. 2004;96(3):286-292.
17. Sanguinetti MC, Spector PS. Potassium Channelopathies. Neuropharmacology. 1997;36(6):755-762.
18. + Channels in Cardiac Muscle. Nature. 1983;305:147-148
19. + Channels. J Biol Chem. 2002;25:40196-40205.
20. + Channels to ATP. J Biol Chem. 2001;276:29098-29103.
21. Aronson JK. Potassium Channels in Nervous Tissue. Blechem Pharmacol. 1992;43(1):11-14.
22. ATP Potassium Channel Openers. Bioorg Med Chem Lett. 1993;3(12):2725-2726.
23. Nurse DA, Restorick JM, Mundy AR. The Effect of Cromakalim on the Normal and Hyperreflexic Human Detrusor Muscle. Br J Urol. 1991;68:27-31.
24. Loev, B, Goodman, MM, Snader, MK, Tedeschi, R, Macko, E, Hantzsch-type Dihidropyridine Hypotensive Agents. J Med Chem. 1974;317(9):956-965.
25. Klöckner U, Trieschmann U, Isenberg G. Pharmacological Modulation of Calcium and Potassium Channels in Isolated Vascular Smooth Muscle Cells. Arzneimittel-Forschung (Drug Research). 1989;39(1):120-126.
26. Ashcroft SJ, Ashcroft FM. Properties and Functions of ATP-sensitive K-channels. Cell Signal. 1990;2(3):197-214.
27. Ashcroft FM, Gribble FM. New Windows on the Mechanism of Action of K(ATP) Channel Openers, Trends Pharmacol Sci. 2000;21(11):439-445.
28. Ashcroft FM, Rorsman R Electrophysiology of the Pancreatic β-cell. Prog Biophys Mol Biol. 1989;54(2):87-143.
29. + Channels. Science 1990;12:276-279.
30. Reinhart PH, Chung S, Levitan IB. A Family of Calcium-dependent Potassium Channels from Rat Brain. Neuron. 1989;2(1):1031-1041.
31. + Channels of Small Conductance in Cultured Rat Skeletal Muscle. Nature. 1986;323:718-720.
32. + Channels, Eur Respir J. 1998;11(3):571-574.
33. Cook NS. The Pharmacology of Potassium Channels and Their Therapeutic Potential. Trends Pharmacol Sci. 1988; 9(l):21-28.
34. + Channels in Porcine Coronary Artery Smooth Muscle Cells. Biochem Biophys Res Commun. 1991;181(2):700-706.
35. Zhang H, Bolton TB. Activation by Intracellular GDP, Metabolic Inhibition and Pinasidil of a Glibenclamide-sensitive K-channel in Smooth Muscle Cells of Rat Mesenteric Artery. Br J Pharmacol. 1995;114(3):662-672.
36. Teramoto N, Brading AF. Activation by Levcromakalim and Metabolic Inhibition of glibenclamide-sensitive K Channels in Smooth Muscle Cells of Pig Proximal Urethra. Br J Pharmacol. 1996;118(3):635-642.
37. Lee SW, Wang HZ, Christ GJ. Characterization of ATP-sensitive Potassium Channels in Human Corporal Smooth Mus-cle Cells. Int J Impot Res. 1999;11(4):179-188.
38. Andersson KE. Advances in the Pharmacological Control of the Bladder, Exp Physiol. 1999;4(1):95-213.